• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2025, Vol. 27 ›› Issue (6): 859-866.DOI: 10.3969/j.issn.1671-2587.2025.06.019

• 综述 • 上一篇    下一篇

有核红细胞在疾病诊断及预后评估中的作用研究进展*

朱源源, 彭芳, 李宁   

  1. 中南大学湘雅医院输血科,湖南长沙 410008
  • 收稿日期:2025-05-26 出版日期:2025-12-20 发布日期:2025-12-24
  • 通讯作者: 李宁,主要从事输血的临床及基础研究,E-mail:liningxy@csu.edu.cn。共同通信作者:彭芳,主要从事肿瘤发病机制研究,E-mail:pengfang@csu.edu.cn。
  • 作者简介:朱源源,主要从事临床检验诊断学,E-mail:zhuyy0605@csu.edu.cn。
  • 基金资助:
    *本课题受国家自然科学基金项目(No.82270633、No.82571796)资助

The Role of Nucleated Red Blood Cells in Diagnosis and Prognosis

ZHU Yuanyuan, PENG Fang, LI Ning   

  1. Department of Blood Transfusion, National Health Commission Key Laboratory of Cancer Proteomics, Xiangya Hospital, Central South University, Changsha 410008
  • Received:2025-05-26 Online:2025-12-20 Published:2025-12-24

摘要: 有核红细胞(nucleated red blood cells, NRBCs)是红细胞生成过程中未成熟的红细胞前体,其显著特征是仍保留细胞核。在生理状态下,NRBCs主要见于孕妇及新生儿的外周血中,在健康成人外周血中几乎不可检出。然而,在血液系统疾病、感染性疾病及恶性肿瘤等病理状态下,NRBCs的外周血水平显著升高,并与患者的不良预后密切相关,已成为潜在的疾病诊断标志物和预后评估指标。本文旨在系统回顾近年来NRBCs作为生物标志物的研究进展,深入探讨其在疾病发生中的分子机制及其在临床诊断、治疗和预后评估中的应用潜力,为相关疾病的精准医疗提供新的视角和策略。

关键词: 有核红细胞, 生物标志物, 疾病诊断, 预后评估

Abstract: Nucleated red blood cells (NRBCs) are immature precursors of red blood cells that retain their nuclei during the process of erythropoiesis. Under physiological conditions, NRBCs are predominantly present in the peripheral blood of pregnant women and neonates, while they are rarely detected in healthy adults. However, their levels in peripheral blood increase significantly under various pathological conditions, including hematological disorders, infectious diseases, and malignancies. This elevation is closely associated with adverse clinical outcomes, making NRBCs promising candidates as diagnostic biomarkers and prognostic indicators. This article aims to provide a comprehensive review of recent advances in NRBC research, with a focus on their molecular mechanisms in disease progression, as well as their potential applications in clinical diagnosis, treatment monitoring, and prognosis evaluation, thereby offering a new insight and strategy for precision medicine.

Key words: Nucleated red blood cells, Biomarkers, Disease diagnosis, Prognosis assessment

中图分类号: